Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company
Independent directors’ opinions on the eighth meeting of the second board of directors
Prior approval opinions on relevant matters
In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the Listing Rules of the Shanghai Stock Exchange, the Listing Rules of the stock exchange of Hong Kong Limited, the rules of independent directors of listed companies and other relevant laws, regulations and normative documents, as well as the Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) articles of Association (hereinafter referred to as the “articles of association”) As the independent director of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company (hereinafter referred to as “the company”), based on the relevant provisions of the working system of independent non-executive directors of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company, we, as the independent director of Cansino Biologics Inc(688185) Jinyu Bio-Technology Co.Ltd(600201) company (hereinafter referred to as “the company”), based on the independent, prudent and objective position and careful analysis, hereby express our prior approval opinions on the company’s renewal of domestic and foreign audit institutions and internal control audit institutions in 2022 and the expected matters of daily connected transactions in 2022 as follows: 1 About hiring domestic and foreign audit institutions and internal control audit institutions in 2022
All independent directors of the company believe that the company’s continued employment of Deloitte Huayong Certified Public Accountants (special general partnership) as a domestic audit institution and internal control audit institution in 2022, and Deloitte Guan Huang Chenfang as an overseas audit institution in 2022 meet the actual situation of the company and the needs of annual audit work. Deloitte Huayong Certified Public Accountants (special general partnership) and Deloitte guanhuang Chenfang certified public accountants have sufficient independence, professional ability of audit services and investor protection ability, and are competent for the annual audit of the company. Therefore, we approved the proposal on hiring domestic and foreign audit institutions and internal control audit institutions in 2022 in advance and agreed that the company would submit the proposal to the eighth meeting of the second board of directors for deliberation.
2、 Forecast of daily related party transactions in 2022
All independent directors of the company believe that the expected events of the company’s daily related party transactions in 2022 are required by the company’s business activities. The related party transactions determine the transaction price fairly, openly and reasonably according to the market transaction principle, which is in line with the interests of the company and all shareholders, has no impact on the independence of the company, and does not damage the interests of the company and shareholders, especially the interests of minority shareholders, and is in line with the interests of the company and all shareholders, Comply with the relevant provisions of China Securities Regulatory Commission and Shanghai Stock Exchange. Therefore, we approved the proposal on the prediction of daily connected transactions in 2022 in advance and agreed that the company would submit the proposal to the eighth meeting of the second board of directors for deliberation.
Independent directors: Wei Shaokun, Xin Zhu, GUI Shuifa, Liu Jianzhong March 24, 2022
